Cargando…
To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841/ https://www.ncbi.nlm.nih.gov/pubmed/35664534 http://dx.doi.org/10.1002/rth2.12738 |
| _version_ | 1784717095099957248 |
|---|---|
| author | Bikdeli, Behnood |
| author_facet | Bikdeli, Behnood |
| author_sort | Bikdeli, Behnood |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9148841 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91488412022-06-04 To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question Bikdeli, Behnood Res Pract Thromb Haemost Commentary John Wiley and Sons Inc. 2022-05-29 /pmc/articles/PMC9148841/ /pubmed/35664534 http://dx.doi.org/10.1002/rth2.12738 Text en © 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentary Bikdeli, Behnood To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title | To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title_full | To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title_fullStr | To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title_full_unstemmed | To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title_short | To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question |
| title_sort | to escalate thromboprophylacic heparin intensity in covid‐19 or not? that is still the question |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841/ https://www.ncbi.nlm.nih.gov/pubmed/35664534 http://dx.doi.org/10.1002/rth2.12738 |
| work_keys_str_mv | AT bikdelibehnood toescalatethromboprophylacicheparinintensityincovid19ornotthatisstillthequestion |